U.S. Preclinical CRO Market (2024 - 2030) Size, Share & Trends Analysis Report By Service (Bioanalysis & DMPK Studies, Toxicology Testing), By Model Type, By Technology, By End-use, By State, And Segment Forecasts

Market Segmentation

U.S. Preclinical CRO Services Outlook (Revenue, USD Million, 2018 - 2030)
- Bioanalysis and DMPK studies
  - In vitro ADME
  - In-vivo PK
- Toxicology Testing
  - GLP
  - Non-GLP
- Compound Management
  - Process R&D
  - Custom Synthesis
  - Others
- Chemistry
  - Medicinal Chemistry
  - Computation Chemistry
- Safety Pharmacology
- Discovery Research
  - Target Identification & Screening
  - Target Validation & Functional Informatics
  - Lead Identification & Candidate Optimization
  - Preclinical Development
  - Other Associated Workflow
- Others
U.S. Preclinical CRO Model Type Outlook (Revenue, USD Million, 2018 - 2030)
- Small Animal Models
  - Mice
  - Rats
  - Rabbits
  - Others
- Large Animal Models
  - Pig
  - Others
- Organoid Models
- Cell Culture Models
- Others
U.S. Preclinical CRO Technology Outlook (Revenue, USD Million, 2018 - 2030)
- In Vivo Studies
- In Vitro Studies
- Ex Vivo Studies
- Imaging Technologies
  - Ultrasound Imaging
  - MRI Imaging
  - CT Imaging
  - Radionuclide Imaging
  - Other Imaging Technologies
- Other Technologies
U.S. Preclinical CRO End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Biopharmaceutical Companies
- Research and Academic Institutes
- Medical Device Companies
U.S. Preclinical CRO State Outlook (Revenue, USD Million, 2018 - 2030)
- New Jersey
- Pennsylvania
- Massachusetts
- Florida
- North Carolina
- Texas
- Illinois
- Indiana
- Michigan
- California
- Rest of the U.S.

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments